Sign In
Buy CTLT
$63.49
+0 (+0%)
At Close: Mar 14, 2025
The Daily Biotech Pulse: Sanofi-GSK Land $2.1B Funding For Coronavirus Vaccine, D-Day For GW Pharma, FDA Nod For Roche
12:00am, Friday, 31'st Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 30)
Achieve Life Sciences Inc (NASDAQ: ACHV)
Annexon Inc (NASDAQ: ANNX) (IPOed July 24)
Atossa Therapeutics...
Drugmakers Race to Build Covid-19 Vaccine Supply Chains
12:41pm, Thursday, 30'th Jul 2020
Pharmaceutical companies that are racing to develop a vaccine for the coronavirus are already working behind the scenes to build the supply chains needed to deliver the drug to billions of people as r
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health
The Race To Erase COVID-19
01:21am, Wednesday, 29'th Jul 2020
As new COVID-19 cases both in the US and globally continue to rise, four leading biotech companies with competing technology offerings race to bring about a medical solution.
Charting a (bullish) holding pattern, S&P 500 digests break to 5-month highs
04:44pm, Tuesday, 28'th Jul 2020
The major U.S. benchmarks are acting well technically, though amid increasingly sideways late-July price action, writes Michael Ashbaugh.
Moderna Gets Another $472M Federal Funding For Late-Stage Coronavirus Vaccine Development
12:00am, Sunday, 26'th Jul 2020
Moderna Inc. (NASDAQ: MRNA) announced Sunday it is receiving another $472 million funding from President Donald Trump's administration to support late-stage...
The Daily Biotech Pulse: Midatech Shelves Sale Plan, G1 Therapeutics Out-Licenses, Entera Bio Jumps On Survey Results
12:00am, Thursday, 23'rd Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 22)
ABIOMED, Inc. (NASDAQ: ABMD)
Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO)
Bio-Rad Laboratories,...
The Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat
12:00am, Wednesday, 22'nd Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 21)
ABIOMED, Inc. (NASDAQ: ABMD)
Assembly Biosciences Inc (NASDAQ: ASMB)
Bio-Rad Laboratories, Inc. (NYSE: BIO)...
Charting a bull-flag breakout, S&P 500 extends rally as volatility recedes
04:24pm, Tuesday, 21'st Jul 2020
Technically speaking, the U.S. benchmarks’ bigger-picture backdrop remains bullish, and continues to strengthen, amid recently receding volatility, writes...
Exchange Traded Concepts LLC Boosts Stock Position in Catalent Inc (NYSE:CTLT)
07:14am, Sunday, 19'th Jul 2020
Exchange Traded Concepts LLC raised its position in shares of Catalent Inc (NYSE:CTLT) by 54.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commiss
IFM Investors Pty Ltd Buys Shares of 11,316 Catalent Inc (NYSE:CTLT)
05:26am, Saturday, 18'th Jul 2020
IFM Investors Pty Ltd bought a new stake in shares of Catalent Inc (NYSE:CTLT) in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 11,316 shares of the company’
Catalent Inc (NYSE:CTLT) Shares Sold by Envestnet Asset Management Inc.
05:48pm, Thursday, 16'th Jul 2020
Envestnet Asset Management Inc. lowered its position in Catalent Inc (NYSE:CTLT) by 0.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission.
Moderna announces publication of interim results from Phase 1 study of its mRNA vaccine against COVID-19 (mRNA-1273) in NEJM.
Did Hedge Funds Make The Right Call On Catalent Inc (CTLT) ?
12:54am, Monday, 13'th Jul 2020
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail invest
Why Investors Should Take Another Look at Moderna’s Many Advantages
06:06pm, Friday, 10'th Jul 2020
After a solid run since starting at the sub-$20 levels at the start of the year, Moderna (NASDAQ:MRNA) continues to attract plenty of buying and selling activity. Ultimately, the direction of MRNA sto
